Fig. 5
From: Combined multi-omics and brain pathology reveal novel biomarkers for alzheimer’s disease
Western blotting validation of proteomics sequencing results. (A, D, E, F) Representative Western blotting images of CD180, EGFL8, C1QB, LY86, and ERMN. Tubulin was used as the internal standard; (B-F) Image J software was used to quantitatively analyze CD180, EGFL8, C1QB, LY86, and ERMN in the hippocampus of two groups. Data are expressed as mean ± SEM; N = 3 mouse/group; * p < 0.05.
